Biomarkers of Coagulation, Inflammation, and Angiogenesis are Independently Associated with Preeclampsia

American Journal of Reproductive Immunology

Volumn 68, Issue 3, 2012, Pages 258-270

  Boij, Roland ^a,b   Svensson, Judit ^b   Nilsson Ekdahl, Kristina ^c,d   Sandholm, Kerstin ^d   Lindahl, Tomas L ^b   Palonek, Elzbieta ^e,f   Garle, Mats ^e,f   Berg, Göran ^b   Ernerudh, Jan ^b   Jenmalm, Maria ^b   Matthiesen, Leif ^b,g  

^a RYHOV COUNTY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d LINNAEUS UNIVERSITY   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f Doping Control Laboratory   (Sweden)

^g HELSINGBORG HOSPITAL   (Sweden)

Author keywords

Angiogenesis; Chemokines; Coagulation; Cytokines and early onset preeclampsia; Inflammation; Preeclampsia

Indexed keywords

ANGIOGENIC FACTOR; ANTITHROMBIN; BETAMETHASONE; BIOLOGICAL MARKER; COMPLEMENT COMPONENT C3A; CXCL11 CHEMOKINE; DEXAMETHASONE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 4; PENTRAXIN 3; PLACENTAL GROWTH FACTOR; PREDNISOLONE; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EARLY ONSET PREECLAMPSIA; FEMALE; HUMAN; INFLAMMATION; LATE ONSET PREECLAMPSIA; PREECLAMPSIA; PRIORITY JOURNAL; SMALL FOR DATE INFANT;

ADULT; ANTITHROMBINS; BIOLOGICAL MARKERS; BLOOD COAGULATION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHEMOKINE CXCL10; CHEMOKINE CXCL11; COMPLEMENT C3A; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-4; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; SERUM AMYLOID P-COMPONENT; STATISTICS, NONPARAMETRIC; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84865300272     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2012.01158.x     Document Type: Article

References (38)

1. Duley L: The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33:130-137.
2. Matthiesen L, Berg G, Ernerudh J, Ekerfelt C, Jonsson Y, Sharma S: Immunology of preeclampsia. Chem Immunol Allergy 2005; 89:49-61.
3. Redman CW: Immunology of preeclampsia. Semin Perinatol 1991; 15:257-262.
4. Redman CW, Sargent IL: Immunology of pre-eclampsia. Am J Reprod Immunol 2010; 63:534-543.
5. Wikstrom AK, Larsson A, Eriksson UJ, Nash P, Norden-Lindeberg S, Olovsson M: Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynecol 2007; 109:1368-1374.
6. Valensise H, Vasapollo B, Gagliardi G, Novelli GP: Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 2008; 52:873-880.
7. Vatten LJ, Skjaerven R: Is pre-eclampsia more than one disease? BJOG 2004; 111:298-302.
8. Redman CW, Sacks GP, Sargent IL: Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180(2 Pt 1):499-506.
9. Alfirevic Z, Roberts D, Martlew V: How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002; 101:6-14.
10. Jonsson Y, Ekerfelt C, Berg G, Nieminen K, Sharma S, Ernerudh J, et al.: Systemic Th1/Th2 cytokine responses to paternal and vaccination antigens in preeclampsia: no differences compared with normal pregnancy. Am J Reprod Immunol 2004; 51:302-310.
11. Lin J, August P: Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 2005; 105:182-192.
12. Jonsson Y, Ruber M, Matthiesen L, Berg G, Nieminen K, Sharma S, et al.: Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol 2006; 70:83-91.
13. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002;99:159-167.
14. Enstrom C, Osman A, Lindahl TL: A genotyping method for VKORC1 1173C > T by Pyrosequencing technology. Scand J Clin Lab Invest 2008; 68:427-430.
15. Nilsson Ekdahl K, Nilsson B, Pekna M, Nilsson UR: Generation of iC3 at the interface between blood and gas. Scand J Immunol 1992; 35:85-91.
16. Mollnes TE, Lea T, Froland SS, Harboe M: Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 1985; 22:197-202.
17. Henningsson AJ, Ernerudh J, Sandholm K, Carlsson SA, Granlund H, Jansson C, et al.: Complement activation in Lyme neuroborreliosis-increased levels of C1q and C3a in cerebrospinal fluid indicate complement activation in the CNS. J Neuroimmunol 2007; 183:200-207.
18. Furuhjelm C, Jenmalm MC, Falth-Magnusson K, Duchen K: Th1 and Th2 Chemokines, Vaccine-Induced Immunity, and Allergic Disease in Infants After Maternal omega-3 Fatty Acid Supplementation During Pregnancy and Lactation. Pediatr Res 2011; 69:259-264.
19. Palonek EöF, Garle M: Screening for corticosteroids in urine with on-line extraction and LC-MSMS detection. Recent Advances in Doping Analysis (13). Sportverlag Strauss, Köln, 2005:47-56.
20. Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, et al.: Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004; 44:708-714.
21. Tosun M, Celik H, Avci B, Yavuz E, Alper T, Malatyalioglu E: Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in normal pregnancies and in pregnancies complicated by preeclampsia. J Matern Fetal Neonatal Med 2010; 23:880-886.
22. Madazli R, Aydin S, Uludag S, Vildan O, Tolun N: Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet Gynecol Scand 2003; 82:797-802.
23. Guven MA, Coskun A, Ertas IE, Aral M, Zencirci B, Oksuz H: Association of maternal serum CRP, IL-6, TNF-alpha, homocysteine, folic acid and vitamin B12 levels with the severity of preeclampsia and fetal birth weight. Hypertens Pregnancy 2009; 28:190-200.
24. Miotto D, Christodoulopoulos P, Olivenstein R, Taha R, Cameron L, Tsicopoulos A, et al.: Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. J Allergy Clin Immunol 2001; 107:664-670.
25. Sandberg M, Frykman A, Ernerudh J, Berg G, Matthiesen L, Ekerfelt C, et al.: Cord blood cytokines and chemokines and development of allergic disease. Pediatr Allergy Immunol 2009; 20:519-527.
26. Stumpf C, Auer C, Yilmaz A, Lewczuk P, Klinghammer L, Schneider M, et al.: Serum levels of the Th1 chemoattractant interferon-gamma-inducible protein (IP) 10 are elevated in patients with essential hypertension. Hypertens Res 2011; 34:484-488.
27. Pease JE, Williams TJ: Chemokines and their receptors in allergic disease. J Allergy Clin Immunol 2006;118:305-318; quiz 319-320.
28. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25:677-686.
29. Kronborg CS, Gjedsted J, Vittinghus E, Hansen TK, Allen J, Knudsen UB: Longitudinal measurement of cytokines in pre-eclamptic and normotensive pregnancies. Acta Obstet Gynecol Scand 2011; 90:791-796.
30. Kocyigit Y, Atamer Y, Atamer A, Tuzcu A, Akkus Z: Changes in serum levels of leptin, cytokines and lipoprotein in pre-eclamptic and normotensive pregnant women. Gynecol Endocrinol 2004; 19:267-273.
31. Kalinderis M, Papanikolaou A, Kalinderi K, Ioannidou E, Giannoulis C, Karagiannis V, et al.: Elevated Serum Levels of Interleukin-6, Interleukin-1beta and Human Chorionic Gonadotropin in Pre-eclampsia. Am J Reprod Immunol 2011; 66:468-475.
32. Kauma S, Takacs P, Scordalakes C, Walsh S, Green K, Peng T: Increased endothelial monocyte chemoattractant protein-1 and interleukin-8 in preeclampsia. Obstet Gynecol 2002; 100:706-714.
33. Hayashi M, Ueda Y, Ohkura T, Inaba N: Interleukin-6 concentrations in the placenta and blood in normal pregnancies and preeclampsia. Horm Metab Res 2005; 37:419-424.
34. Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T: Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. BJOG 2002; 109:759-764.
35. Rampersad R, Barton A, Sadovsky Y, Nelson DM: The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro. Placenta 2008; 29:855-861.
36. Haeger M, Unander M, Bengtsson A: Complement activation in relation to development of preeclampsia. Obstet Gynecol 1991; 78:46-49.
37. Varughese B, Bhatla N, Kumar R, Dwivedi SN, Dhingra R: Circulating angiogenic factors in pregnancies complicated by pre-eclampsia. Natl Med J India 2010; 23:77-81.
38. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ: Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 2010; 122:478-487.